La Jolla Pharmaceutical Shares Outstanding 2006-2018 | LJPC

La Jolla Pharmaceutical shares outstanding history from 2006 to 2018. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • La Jolla Pharmaceutical shares outstanding for the quarter ending June 30, 2018 were 0.026B, a 18.35% increase year-over-year.
  • La Jolla Pharmaceutical 2017 shares outstanding were 0.021B, a 23.14% increase from 2016.
  • La Jolla Pharmaceutical 2016 shares outstanding were 0.017B, a 10.08% increase from 2015.
  • La Jolla Pharmaceutical 2015 shares outstanding were 0.016B, a 46.72% increase from 2014.
La Jolla Pharmaceutical Annual Shares Outstanding
(Millions of Shares)
2017 21
2016 17
2015 16
2014 11
2013 2
2012 0
2011 0
2010 0
2009 63
2008 50
2007 38
2006 33
2005 15
La Jolla Pharmaceutical Quarterly Shares Outstanding
(Millions of Shares)
Q2 2018 26
Q1 2018 23
Q4 2017 21
Q3 2017 22
Q2 2017 22
Q1 2017 18
Q4 2016 17
Q3 2016 17
Q2 2016 17
Q1 2016 17
Q4 2015 16
Q3 2015 15
Q2 2015 15
Q1 2015 15
Q4 2014 11
Q3 2014 14
Q2 2014 8
Q1 2014 6
Q4 2013 2
Q3 2013 1
Q2 2013 1
Q1 2013 0
Q4 2012 0
Q3 2012 0
Q2 2012 0
Q1 2012 109
Q4 2011 0
Q3 2011 0
Q2 2011 11
Q1 2011 0
Q4 2010 0
Q3 2010 0
Q2 2010 0
Q1 2010 0
Q4 2009 63
Q3 2009 66
Q2 2009 66
Q1 2009 56
Q4 2008 50
Q3 2008 55
Q2 2008 48
Q1 2008 40
Q4 2007 38
Q3 2007 40
Q2 2007 39
Q1 2007 33
Q4 2006 33
Q3 2006 33
Q2 2006 33
Q1 2006 32
Q4 2005 15
Q3 2005 15
Q2 2005 15
Q1 2005 14
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.579B $0.001B
LA JOLLA PHARMACEUTICAL CO. is engaged in the research and development of therapeutic products for the treatment of autoimmune and inflammatory diseases.
Stock Name Country Market Cap PE Ratio
Shire (SHPG) Ireland $54.280B 11.50
Zoetis (ZTS) United States $42.921B 31.15
Tilray (TLRY) United States $19.938B 0.00
Grifols (GRFS) Spain $14.394B 18.66
Neurocrine Biosciences (NBIX) United States $10.622B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $9.849B 14.49
Nektar Therapeutics (NKTR) United States $9.777B 11.43
Impax Laboratories (AMRX) United States $7.103B 37.78
Ionis Pharmaceuticals (IONS) United States $6.861B 0.00
Sage Therapeutics (SAGE) United States $6.758B 0.00
Catalent (CTLT) United States $6.192B 26.71
United Therapeutics (UTHR) United States $5.483B 7.04
FibroGen (FGEN) United States $4.748B 0.00
Loxo Oncology (LOXO) United States $4.746B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.904B 15.12
Endo (ENDP) Ireland $3.574B 5.13
Madrigal Pharmaceuticals (MDGL) United States $3.316B 0.00
USANA Health Sciences (USNA) United States $2.895B 25.50
Heron Therapeutics (HRTX) United States $2.620B 0.00
Ironwood Pharmaceuticals (IRWD) United States $2.619B 0.00
Aerie Pharmaceuticals (AERI) United States $2.541B 0.00
Xencor (XNCR) United States $2.516B 0.00
PTC Therapeutics (PTCT) United States $2.281B 0.00
Spectrum Pharmaceuticals (SPPI) United States $2.188B 0.00
Pacira Pharmaceuticals (PCRX) United States $2.103B 0.00
TESARO (TSRO) United States $2.032B 0.00
Portola Pharmaceuticals (PTLA) United States $1.892B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.784B 21.82
Zogenix (ZGNX) United States $1.686B 0.00
Corcept Therapeutics (CORT) United States $1.650B 25.39
Arrowhead Pharmaceuticals (ARWR) United States $1.635B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.515B 0.00
Tricida (TCDA) United States $1.499B 0.00
TherapeuticsMD (TXMD) United States $1.440B 0.00
ImmunoGen (IMGN) United States $1.314B 0.00
Endocyte (ECYT) United States $1.234B 0.00
Esperion Therapeutics (ESPR) United States $1.221B 0.00
Karyopharm Therapeutics (KPTI) United States $1.120B 0.00
Radius Health (RDUS) United States $0.839B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.802B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.763B 0.00
Flexion Therapeutics (FLXN) United States $0.742B 0.00
Dova Pharmaceuticals (DOVA) United States $0.694B 0.00
GlycoMimetics (GLYC) United States $0.626B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.598B 0.00
ChemoCentryx (CCXI) United States $0.581B 34.79
OptiNose (OPTN) United States $0.563B 0.00
Siga Technologies (SIGA) United States $0.529B 0.00
ArQule (ARQL) United States $0.528B 0.00
Odonate Therapeutics (ODT) United States $0.525B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.498B 0.00
CASI Pharmaceuticals (CASI) United States $0.496B 0.00
Collegium Pharmaceutical (COLL) United States $0.494B 0.00
Aclaris Therapeutics (ACRS) United States $0.479B 0.00
Translate Bio (TBIO) United States $0.467B 0.00
Dermira (DERM) United States $0.455B 0.00
Xeris Pharmaceuticals (XERS) United States $0.447B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.442B 0.00
Akebia Therapeutics (AKBA) United States $0.442B 0.00
Minerva Neurosciences (NERV) United States $0.430B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.424B 28.94
Synergy Pharmaceuticals (SGYP) United States $0.424B 0.00
Zafgen (ZFGN) United States $0.411B 0.00
Aquestive Therapeutics (AQST) United States $0.409B 0.00
Forty Seven (FTSV) United States $0.408B 0.00
ElectroCore (ECOR) United States $0.396B 0.00
Mast Therapeutics (SVRA) United States $0.393B 0.00
Depomed (ASRT) United States $0.381B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.375B 0.00
MEI Pharma (MEIP) United States $0.323B 0.00
Concert Pharmaceuticals (CNCE) United States $0.322B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.322B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.315B 0.00
Opexa Therapeutics (ACER) United States $0.298B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.296B 0.00
Affimed (AFMD) Germany $0.293B 0.00
Aratana Therapeutics (PETX) United States $0.278B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.276B 0.00
Tyme Technologies (TYME) United States $0.271B 0.00
Ardelyx (ARDX) United States $0.254B 0.00
Melinta Therapeutics (MLNT) United States $0.251B 0.00
Ocular Therapeutix (OCUL) United States $0.248B 0.00
Galectin Therapeutics (GALT) United States $0.248B 0.00
IMV INC (IMV) Canada $0.239B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.227B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.224B 0.00
Neon Therapeutics (NTGN) United States $0.221B 0.00
Jounce Therapeutics (JNCE) United States $0.218B 0.00
Achaogen (AKAO) United States $0.206B 0.00
KalVista Pharmaceuticals (KALV) United States $0.205B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.203B 0.00
Lannett Co Inc (LCI) United States $0.189B 1.56
DURECT (DRRX) United States $0.178B 0.00
Nature's Sunshine Products (NATR) United States $0.174B 0.00
MediWound (MDWD) Israel $0.173B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.171B 0.00
Redhill Biopharma (RDHL) Israel $0.170B 0.00
Molecular Templates (MTEM) United States $0.169B 0.00
Calithera Biosciences (CALA) United States $0.169B 0.00
Aldeyra Therapeutics (ALDX) United States $0.169B 0.00
Immune Design (IMDZ) United States $0.166B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.162B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.159B 0.00
Champions Oncology (CSBR) United States $0.156B 0.00
Adherex Technologies (FENC) United States $0.156B 0.00
Recro Pharma (REPH) United States $0.155B 0.00
Cardiome Pharma (CORV) Canada $0.153B 0.00
Neos Therapeutics (NEOS) United States $0.145B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.140B 0.00
ProNAi Therapeutics (SRRA) Canada $0.139B 0.00
Infinity Pharmaceuticals (INFI) United States $0.131B 0.00
ContraFect (CFRX) United States $0.130B 0.00
Forward Pharma (FWP) Denmark $0.124B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.116B 0.00
Iterum Therapeutics (ITRM) Ireland $0.115B 0.00
Rafael Holdings (RFL) United States $0.114B 0.00
CTI BioPharma (CTIC) United States $0.111B 0.00
BioLineRx (BLRX) Israel $0.099B 0.00
Nivalis Therapeutics (ALPN) United States $0.089B 0.00
Trillium Therapeutics (TRIL) Canada $0.088B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.087B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.081B 0.00
Otonomy (OTIC) United States $0.080B 0.00
KemPharm (KMPH) United States $0.079B 0.00
Novan (NOVN) United States $0.075B 0.00
Natural Alternatives (NAII) United States $0.073B 8.18
Opiant Pharmaceuticals (OPNT) United States $0.062B 52.60
SCYNEXIS (SCYX) United States $0.058B 0.00
Ampio Pharmaceuticals (AMPE) United States $0.053B 0.00
India Globalization Capital (IGC) United States $0.052B 0.00
Mannatechorporated (MTEX) United States $0.049B 25.63
Tokai Pharmaceuticals (NVUS) United States $0.046B 0.00
Genocea Biosciences (GNCA) United States $0.044B 0.00
Capnia (SLNO) United States $0.044B 0.00
Heat Biologics (HTBX) United States $0.043B 0.00
Onconova Therapeutics (ONTX) United States $0.040B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.038B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.037B 0.00
ProPhase Labs (PRPH) United States $0.035B 3.90
Avenue Therapeutics (ATXI) United States $0.035B 0.00
Lipocine (LPCN) United States $0.033B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.032B 0.00
Biomerica (BMRA) United States $0.030B 0.00
IsoRay (ISR) United States $0.030B 0.00
Jaguar Animal Health (JAGX) United States $0.028B 0.00
NanoViricides (NNVC) United States $0.028B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.028B 0.00
Can-Fite Biopharma (CANF) Israel $0.026B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.024B 0.00
Citius Pharmaceuticals (CTXR) United States $0.024B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.024B 0.00
HANCOCK JAFFE (HJLI) United States $0.023B 0.00
Midatech Pharma (MTP) United Kingdom $0.022B 0.00
Shineco (TYHT) China $0.022B 1.85
PharmAthene (ALT) United States $0.021B 0.00
Cyanotech (CYAN) United States $0.020B 0.00
Xenetic Biosciences (XBIO) United States $0.020B 0.00
Regulus Therapeutics (RGLS) United States $0.020B 0.00
Aradigm (ARDM) United States $0.018B 0.00
ESSA Pharma (EPIX) Canada $0.018B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.018B 0.00
Aviragen Therapeutics (VXRT) United States $0.017B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.016B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.015B 0.00
Skyline Medical (AIPT) United States $0.013B 0.00
Intellipharmaceutics (IPCI) Canada $0.012B 0.00
Bio-Path Holdings (BPTH) United States $0.011B 0.00
OncoGenex Pharmaceuticals (ACHV) United States $0.011B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.010B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.010B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.009B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.007B 0.00
Pain Therapeutics (PTIE) United States $0.007B 0.00
Apricus Biosciences (APRI) United States $0.007B 0.00
RXi Pharmaceuticals (RXII) United States $0.005B 0.00
Bio Blast Pharma (ORPN) Israel $0.004B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.002B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00